Hena Khalique

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Journal for immunotherapy of cancer

Cancers

University of Oxford

Universidad Autonoma de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oxford Dec 01 2017

United Kingdom

Postdoctoral researcher :: Oncology

Education History

Universidad Autonoma de Madrid Mar 01 2010 - Jun 18 2015

Spain

PHD :: Molecular Biology

Publications

Richard Baugh, Hena Khalique, Emma Page, Janet Lei-Rossmann, Peter Kok-Ting Wan, Timothy Johanssen, Daniel Ebner, Olaf Ansorge, Leonard W Seymour
Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells. Journal for immunotherapy of cancer 12 (5) (2024)
Richard Baugh, Hena Khalique, Emma Page, Janet Lei-Rossmann, Peter Kok-Ting Wan, Timothy Johanssen, Daniel Ebner, Olaf Ansorge, Leonard W Seymour
Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells. Journal for immunotherapy of cancer 12 (5) (2024)
Richard Baugh, Hena Khalique, Emma Page, Janet Lei-Rossmann, Peter Kok-Ting Wan, Timothy Johanssen, Daniel Ebner, Olaf Ansorge, Leonard W Seymour
Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells. Journal for immunotherapy of cancer 12 (5) (2024)
Richard Baugh, Hena Khalique, Emma Page, Janet Lei-Rossmann, Peter Kok-Ting Wan, Timothy Johanssen, Daniel Ebner, Olaf Ansorge, Leonard W Seymour
Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells. Journal for immunotherapy of cancer 12 (5) (2024)
Hena Khalique, Richard Baugh, Arthur Dyer, Eleanor M Scott, Sally Frost, Sarah Larkin, Janet Lei-Rossmann, Leonard W Seymour
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy. Journal for immunotherapy of cancer 9 (4) (2021)
Richard Baugh, Hena Khalique, Leonard W Seymour
Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response. Cancers 12 (12) (2020)

Hena Khalique.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hena Khalique